BIOMAT Database Logo BIOMAT Database Logo

[A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases]. 1993

T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
Third Department of Internal Medicine, Kyoto Prefectural University of Medicine.

Eighty-six patients with infections associated with hematological disorders were treated with sulbactam/cefoperazone (SBT/CPZ) and amikacin (AMK). Among 71 evaluable cases, 30 cases had acute non-lymphocytic leukemia, 3 acute lymphoblastic leukemia, 25 malignant lymphoma, and 7 myelodysplastic syndrome as underlying diseases. Excellent responses were obtained in 33 cases (46.5%) and good responses in 14 cases (19.7%), with an overall efficacy rate of 66.2%. The efficacy rate among cases with suspected sepsis was 72.5%. This treatment was also effective in 69.2% of cases in which neutrophil counts were less than 500/microliter through the course of administration. The eradication rate was 83.3% among 6 strains in which Gram-negative rods were detected. Side effects were minimum; skin rash in 1 case, slight elevation of APTT in 3 and slight elevation of total bilirubin in 1. Thus, this combination antibacterial chemotherapy is an effective and safe regimen for the treatment of severe infections in patients with hematological disorders.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
April 1995, The Japanese journal of antibiotics,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
October 1993, The Japanese journal of antibiotics,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
August 1993, The Japanese journal of antibiotics,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
August 1989, The Japanese journal of antibiotics,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
September 1991, The Japanese journal of antibiotics,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
August 1992, The Japanese journal of antibiotics,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[Combined clinical effect of amikacin and cefoxitin in patients with severe infections complicated by hematological diseases].
March 1987, The Japanese journal of antibiotics,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
Efficacy of sulbactam/cefoperazone for the treatment of infections in patients with hematologic diseases.
January 1989, Diagnostic microbiology and infectious disease,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders].
June 1990, The Japanese journal of antibiotics,
T Takashima, and S Tsuda, and S Misawa, and S Horiike, and Y Kuzuyama, and K Hirakawa, and H Nakai, and T Seriu, and S Tanaka, and K Nishida
[Sulperazone--a combined form of cefoperazone with sulbactam].
February 1995, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
Copied contents to your clipboard!